Statement
22 Sep 2023
Statement at the High Level Meeting on Tuberculosis
On 22 September 2023, IFPMA submitted a statement at the High-Level Meeting on Tuberculosis in New York.
Read more
Press release
13 Sep 2023
Ahead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity
Ahead of discussions at the United Nations General Assembly (UNGA78), the trade association representing the innovative pharmaceutical industry, the IFPMA, has warned that current pandemic preparedness plans should not undermine what worked well in response to COVID-19 and must support both “innovation and equity.”
Read more
Statement
21 Jul 2023
Joint Plenary Meeting of the Intergovernmental Negotiating Body (INB) and the Working Group on Amendments to the International Health Regulations: Agenda item 2
On 21 July, IFPMA delivered a statement for agenda item 2 at the “Joint Plenary Meeting of the Intergovernmental Negotiating Body (INB) to draft and negotiate a WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response and the Working Group on Amendments to the International Health Regulations (WGIHR) (2005)” in Geneva.
Read more
